Skip to main content

Abstract

Inflammatory bowel diseases (IBDs) affect especially young patients in reproductive age. IBDs consist in a group of chronic inflammatory conditions that mainly affect the colon and the small intestine. The most frequent IBDs are Crohn’s disease and ulcerous colitis (UC) disease. IBDs significantly affect several reproductive aspects, not only fertility but sexual function. The goal of this chapter is to offer readers a detailed description of these two diseases from prevalence and etiology to clinical manifestations diagnosis and treatment and the effect of both diseases on the reproductive function.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Palomba S, Sereni G, Falbo A, Beltrami M, Lombardini S, Boni MC, et al. Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review. World J Gastroenterol. 2014;20(23):7123–36.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Tontini GE, Rath T, Neumann H. Advanced gastrointestinal endoscopic imaging for inflammatory bowel diseases. World J Gastroenterol. 2016;22(3):1246–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2013;58(2):519–25.

    Article  PubMed  Google Scholar 

  4. Lovasz BD, Golovics PA, Vegh Z, Lakatos PL. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Dis Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2013;45(4):269–76.

    Google Scholar 

  5. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–94.

    Article  PubMed  Google Scholar 

  6. Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointestinal Pharmacol Therapeutics. 2016;7(1):5–20.

    Article  Google Scholar 

  7. Solina G, Mandala S, La Barbera C, Mandala V. Current management of intestinal bowel disease: the role of surgery. Updat Surg. 2016;68(1):13–23.

    Article  Google Scholar 

  8. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140(6):1729–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474(7351):298–306.

    Article  CAS  PubMed  Google Scholar 

  11. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329–42.

    Article  CAS  PubMed  Google Scholar 

  12. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastr Pharmacol Th. 2016;7(1):5–20.

    Article  Google Scholar 

  14. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol. 2012;9(4):219–30.

    Article  CAS  PubMed  Google Scholar 

  15. Bamias G, Pizarro T, Cominelli F. New paradigms in the pathogenesis of IBD. Inflamm Bowel Dis. 2011;18:41–57.

    Article  Google Scholar 

  16. Maggiori L, Panis Y. Laparoscopy in Crohn’s disease. Best Pract Res Clin Gastroenterol. 2014;28(1):183–94.

    Article  PubMed  Google Scholar 

  17. Aarons CB. Laparoscopic surgery for crohn disease: a brief review of the literature. Clin Colon Rectal Surg. 2013;26(2):122–7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lim JY, Kim J, Nguyen SQ. Laparoscopic surgery in the management of Crohn’s disease. World J Gastrointestinal Pathophysiol. 2014;5(3):200–4.

    Google Scholar 

  19. Meier J, Sturm A. Current treatment of ulcerative colitis. World J Gastroenterol. 2011;17(27):3204–12.

    PubMed  PubMed Central  Google Scholar 

  20. Matsumoto T, Kudo T, Jo Y, Esaki M, Yao T, Iida M. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. Gastrointest Endosc. 2007;66(5):957–65.

    Article  PubMed  Google Scholar 

  21. Gheorghe C, Pascu O, Gheorghe L, Iacob R, Dumitru E, Tantau M, et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur J Gastroenterol Hepatol. 2004;16(11):1153–9

    Google Scholar 

  22. Tesija KA. Serological markers of inflammatory bowel disease. Biomark Med. 2013;23:28–42.

    Google Scholar 

  23. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42; quiz e30.

    Google Scholar 

  24. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet. 2006;367(9518):1271–84.

    Article  CAS  PubMed  Google Scholar 

  25. Jess T, Riis L, Jespersgaard C, Hougs L, Andersen PS, Orholm MK, et al. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol. 2005;100(11):2486–92.

    Article  CAS  PubMed  Google Scholar 

  26. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mikhailov T-A. Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children. World J Gastroenterol. 2009;15(3):270.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol. 2010;6(5):339–46.

    Google Scholar 

  29. Ng SC, Woodrow S, Patel N, Subhani J, Harbord M. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(4):725–36.

    Article  PubMed  Google Scholar 

  30. Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G, et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis. 2011;17(12):2558–65.

    Article  PubMed  Google Scholar 

  31. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol. 1995;30(7):699–706.

    Article  CAS  PubMed  Google Scholar 

  32. Peyrin-Biroulet L, Loftus Jr EV, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Inflamm Bowel Dis. 2011;17(1):471–8.

    Article  PubMed  Google Scholar 

  33. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106(1):110–9.

    Article  PubMed  Google Scholar 

  34. Froslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133(2):412–22.

    Article  PubMed  Google Scholar 

  35. Bharadwaj S, Kulkarni G, Shen B. Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery. J Dig Dis. 2015;16(5):245–55.

    Article  PubMed  Google Scholar 

  36. Moore J, Barlow D, Jewell D, Kennedy S. Do gastrointestinal symptoms vary with the menstrual cycle? Br J Obstet Gynaecol. 1998;105(12):1322–5.

    Article  CAS  PubMed  Google Scholar 

  37. Bjornsson B, Orvar KB, Theodors A, Kjeld M. The relationship of gastrointestinal symptoms and menstrual cycle phase in young healthy women. Laeknabladid. 2006;92(10):677–82.

    PubMed  Google Scholar 

  38. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103(3):631–6.

    Article  PubMed  Google Scholar 

  39. Lim SM, Nam CM, Kim YN, Lee SA, Kim EH, Hong SP, et al. The effect of the menstrual cycle on inflammatory bowel disease: a prospective study. Gut and liver. 2013;7(1):51–7.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Loftus CG, Loftus Jr EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton 3rd LJ, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13(3):254–61.

    Article  PubMed  Google Scholar 

  41. Stewenius J, Adnerhill I, Ekelund G, Floren CH, Fork FT, Janzon L, et al. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol. 1995;30(1):38–43.

    Article  CAS  PubMed  Google Scholar 

  42. Manousos ON, Giannadaki E, Mouzas IA, Tzardi M, Koutroubakis I, Skordilis P, et al. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol. 1996;8(9):893–8.

    CAS  PubMed  Google Scholar 

  43. Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol. 2006;12(38):6167–71.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Chan Heyson C-h, Kim DH, Lung PFC, Cheon JH, Ng SC. Complications of inflammatory bowel disease. In: Atlas of Inflammatory Bowel Diseases. W.H. Kim, J.H. Cheon (eds.). Berlin, Heidelberg: Springer, 2015. p. 175–86.

    Google Scholar 

  45. Xiang J-Y. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol. 2008;14(1):53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Burger D, Travis S. Conventional medical management of inflammatory bowel disease. Gastroenterology. 2011;140(6):1827–37 e2.

    Article  PubMed  Google Scholar 

  47. Terdiman JP, Gruss CB, Heidelbaugh JJ, Sultan S, Falck-Ytter YT. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-alpha biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013;145(6):1459–63.

    Article  PubMed  Google Scholar 

  48. Ellul P, Zammita SC, Katsanos KH, Cesarini M, Allocca M, Danese S, et al. Perception of reproductive health in women with inflammatory bowel disease. J Crohn’s Colitis. 2016;10(8):886–91.

    Google Scholar 

  49. Rungoe C, Simonsen J, Riis L, Frisch M, Langholz E, Jess T. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterolo Asso. 2015;13(4):693–700 e1.

    Google Scholar 

  50. Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn’s Colitis. 2014;8(6):443–68.

    Article  CAS  Google Scholar 

  51. Sanchez-Tembleque MD, Corella C, Perez-Calle JL. Vaccines and recommendations for their use in inflammatory bowel disease. World J Gastroenterol. 2013;19(9):1354–8.

    Article  PubMed  PubMed Central  Google Scholar 

  52. McConnell RA, Mahadevan U. Use of immunomodulators and biologics before, during, and after pregnancy. Inflamm Bowel Dis. 2016;22(1):213–23.

    Article  PubMed  Google Scholar 

  53. Cottone M, Renna S, Modesto I, Orlando A. Is 5-ASA still the treatment of choice for ulcerative colitis? Curr Drug Targets. 2011;12(10):1396–405.

    Article  CAS  PubMed  Google Scholar 

  54. Probert C. Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma. Therapeutic Adv Gastroenterol. 2013;6(1):33–8.

    Article  CAS  Google Scholar 

  55. Regueiro M, Loftus Jr EV, Steinhart AH, Cohen RD. Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement. Inflamm Bowel Dis. 2006;12(10):972–8.

    Article  PubMed  Google Scholar 

  56. Donnellan CF, Yann LH, Lal S. Nutritional management of Crohn’s disease. Ther Adv Gastroenterol. 2013;6(3):231–42.

    Article  Google Scholar 

  57. Malafosse M. Crohn’s disease: current surgical treatment. Bulletin de l’Academie nationale de medecine. 2007;191(6):1143–56; discussion 57–8.

    Google Scholar 

  58. Tavernier M, Lebreton G, Alves A. Laparoscopic surgery for complex Crohn’s disease. J Vis Surg. 2013;150(6):389–93.

    Article  CAS  Google Scholar 

  59. Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version). Rev Gastroenterol Mex. 2015;80(1):32–73.

    CAS  PubMed  Google Scholar 

  60. Hueting WE, Buskens E, van der Tweel I, Gooszen HG, van Laarhoven CJ. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg. 2005;22(1-2):69–79.

    Article  PubMed  Google Scholar 

  61. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55(11):1575–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Beaulieu DB, Kane S. Inflammatory bowel disease in pregnancy. World J Gastroenterol. 2011;17(22):2696–701.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Ban L, Tata LJ, Humes DJ, Fiaschi L, Card T. Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study. Aliment Pharmacol Ther. 2015;42(7):855–66.

    Article  CAS  PubMed  Google Scholar 

  64. Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS. Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Color Dis. 2011;26(11):1365–74.

    Article  Google Scholar 

  65. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis. 2009;15(5):720–5.

    Article  PubMed  Google Scholar 

  66. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(5):591–9.

    Article  PubMed  Google Scholar 

  67. Manosa M, Navarro-Llavat M, Marin L, Zabana Y, Cabre E, Domenech E. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol. 2013;48(4):427–32.

    Article  PubMed  Google Scholar 

  68. Muller KR, Prosser R, Bampton P, Mountifield R, Andrews JM. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis. 2010;16(4):657–63.

    Article  PubMed  Google Scholar 

  69. Marin L, Manosa M, Garcia-Planella E, Gordillo J, Zabana Y, Cabre E, et al. Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey. J Gastroenterol. 2013;48(6):713–20.

    Article  PubMed  Google Scholar 

  70. Wikland M, Jansson I, Asztely M, Palselius I, Svaninger G, Magnusson O, et al. Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Color Dis. 1990;5(1):49–52.

    Article  CAS  Google Scholar 

  71. Oza SS, Pabby V, Dodge LE, Hacker MR, Fox JH, Moragianni VA, et al. Factors associated with the success of in vitro fertilization in women with inflammatory bowel bisease. digestive diseases and sciences. 2016;61(8):2381–8.

    Google Scholar 

  72. Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(8):847–53.

    Article  CAS  PubMed  Google Scholar 

  73. Khosla R, Willoughby CP, Jewell DP. Crohn’s disease and pregnancy. Gut Liver. 1984;25(1):52–6.

    Article  CAS  Google Scholar 

  74. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstetrics Off Organ Inter Federation Gynaecol Obstetrics. 1997;58(2):229–37.

    Google Scholar 

  75. Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Asso. 2007;5(1):87–94.

    Google Scholar 

  76. Nielsen MJ, Norgaard M, Holland-Fisher P, Christensen LA. Self-reported antenatal adherence to medical treatment among pregnant women with Crohn’s disease. Aliment Pharmacol Ther. 2010;32(1):49–58.

    Article  CAS  PubMed  Google Scholar 

  77. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol. 1984;6(3):211–6.

    CAS  PubMed  Google Scholar 

  78. Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis. 2008;14(12):1736–50.

    Article  PubMed  Google Scholar 

  79. Diamond MP, Freeman ML. Clinical implications of postsurgical adhesions. Hum Reprod Update. 2001;7(6):567–76.

    Article  CAS  PubMed  Google Scholar 

  80. Oresland T, Palmblad S, Ellstrom M, Berndtsson I, Crona N, Hulten L. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Color Dis. 1994;9(2):77–81.

    Article  CAS  Google Scholar 

  81. Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum. 2007;50(8):1128–38.

    Article  PubMed  Google Scholar 

  82. Arkuran C, McComb P. Crohn’s disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol. 2000;27(1):12–3.

    CAS  PubMed  Google Scholar 

  83. Oza SS, Pabby V, Dodge LE, Moragianni VA, Hacker MR, Fox JH, et al. In vitro fertilization in women with inflammatory bowel disease is as successful as in women from the general infertility population. Clini Gastroenterol Hepatol Off Clini Pract J Am Gastroenterol Asso. 2015;13(9):1641–6 e3.

    Google Scholar 

  84. Pabby V, Oza SS, Dodge LE, Hacker MR, Moragianni VA, Correia K, et al. In vitro fertilization is successful in women with ulcerative colitis and ileal pouch anal anastomosis. Am J Gastroenterol. 2015;110(6):792–7.

    Article  PubMed  Google Scholar 

  85. Long MD. Infertility in inflammatory bowel diseases: a cause for hope? Clin Gastroenterol Hepatol Off Clini Pract J Am Gastroenterol Asso. 2015;13(9):1647–9.

    Google Scholar 

  86. Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol. 2000;95(11):3165–70.

    Article  CAS  PubMed  Google Scholar 

  87. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002;97(3):641–8.

    Article  PubMed  Google Scholar 

  88. Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Crohn’s disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Asso. 2010;8(6):509–15.

    Google Scholar 

  89. Molnar T, Farkas K, Nagy F, Lakatos PL, Miheller P, Nyari T, et al. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study. Scand J Gastroenterol. 2010;45(11):1302–6.

    Article  PubMed  Google Scholar 

  90. Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis. 2011;17(3):795–801.

    Article  PubMed  Google Scholar 

  91. Getahun D, Fassett MJ, Longstreth GF, Koebnick C, Langer-Gould AM, Strickland D, et al. Association between maternal inflammatory bowel disease and adverse perinatal outcomes. J Perinatol Off J Calif Perinat Assoc. 2014;34(6):435–40.

    Article  CAS  Google Scholar 

  92. Broms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis. 2014;20(6):1091–8.

    PubMed  Google Scholar 

  93. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Maternal-Fetal Neonat Med Off J Eur Asso Perinatal Med F Asia Oceania Perinatal Soc Inter Soc Perinatal Obstet. 2004;15(4):237–41.

    Article  CAS  Google Scholar 

  94. Elbaz G, Fich A, Levy A, Holcberg G, Sheiner E. Inflammatory bowel disease and preterm delivery. Inter J Gynaecol Obst Off Organ Inter Fed Gynaecol Obstetrics. 2005;90(3):193–7.

    Article  Google Scholar 

  95. Mahadevan U, Kane S. American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131(1):278–82.

    Article  PubMed  Google Scholar 

  96. Abhyankar A, Ham M, Moss AC. Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(5):460–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Asso. 2009;7(3):329–34.

    Google Scholar 

  98. Julsgaard M, Norgaard M, Hvas CL, Buck D, Christensen LA. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflamm Bowel Dis. 2011;17(7):1573–80.

    Article  PubMed  Google Scholar 

  99. Ujihara M, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, et al. Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis. BMC Res Notes. 2013;6:210

    Google Scholar 

  100. Julsgaard M, Norgaard M, Hvas CL, Grosen A, Hasseriis S, Christensen LA. Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn’s disease. Scand J Gastroenterol. 2014;49(8):958–66.

    Article  PubMed  Google Scholar 

  101. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol. 2008;103(5):1203–9.

    Article  CAS  PubMed  Google Scholar 

  102. Food and Drug Administration, HHS. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule. Fed Regist. 2014;79(233):72063–103.

    Google Scholar 

  103. Feagins LA, Kane SV. Sexual and reproductive issues for men with inflammatory bowel disease. Am J Gastroenterol. 2009;104(3):768–73.

    Article  PubMed  Google Scholar 

  104. Sato A, Naganuma M, Asakura K, Nishiwaki Y, Yajima T, Hisamatsu T, et al. Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease. J Crohn’s Colitis. 2010;4(2):183–8.

    Article  Google Scholar 

  105. Sands K, Jansen R, Zaslau S, Greenwald D. Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive. Aliment Pharmacol Ther. 2015;41(9):821–34.

    Article  CAS  PubMed  Google Scholar 

  106. Sills ES, Tucker MJ. First experience with intracytoplasmic sperm injection for extreme oligozoospermia associated with Crohn's disease and 6-mercaptopurine chemotherapy. Asian J Androl. 2003;5(1):76–8.

    PubMed  Google Scholar 

  107. Freour T, Miossec C, Bach-Ngohou K, Dejoie T, Flamant M, Maillard O, et al. Ovarian reserve in young women of reproductive age with Crohn’s disease. Inflamm Bowel Dis. 2012;18(8):1515–22.

    Article  PubMed  Google Scholar 

  108. Senates E, Colak Y, Erdem ED, Yesil A, Coskunpinar E, Sahin O, et al. Serum anti-Mullerian hormone levels are lower in reproductive-age women with Crohn’s disease compared to healthy control women. J Crohn’s Colitis. 2013;7(2):e29–34.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Goetsch, A.L., Kimelman, D., Woodruff, T.K. (2017). Digestive Autoimmune Diseases: Inflammatory Bowel Disease. In: Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Springer, Cham. https://doi.org/10.1007/978-3-319-52316-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52316-3_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52315-6

  • Online ISBN: 978-3-319-52316-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics